The New Era of Inflammatory Disease Management Through the Application of Biosimilar Therapeutics

Mar 31, 2023

- Mar 30, 2024

1.5

Claim your AMA PRA Category 1 Credit(s) or CPE Contact Hour(s) (CEUs) credit

This course is available for logged in users only. Please login or register to take the course.

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...

Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Th...